• About Us
  • Kevin Dooley, MD
  • Contact Us
Cure IBM
  • Home
  • IBM FAQ
  • Diagnosis
    • IBM Diagnosis
    • Symptoms
    • Examination
    • Blood Tests
    • Electromyography (EMG) and Nerve Conduction Studies
    • Magnetic Resonance Imaging (MRI)
    • Muscle Biopsy
    • Misdiagnosis
  • Treatment
    • IBM Treatment
    • Medications
    • Clinical Trials
    • Exercise
    • Nutrition and Weight Control
    • Falls
    • Swallowing
    • Psychology
  • Resources
    • Links
    • Glossary
  • IBM Blog
  • Donate
Menu
$68,245 Grant Available for Study of Inclusion Body Myositis

$68,245 Grant Available for Study of Inclusion Body Myositis

by Kevin Dooley, MD | Aug 26, 2020 | News and Information

You can Bike, Walk, Run, or Ride for IBM on Saturday, June 13!

You can Bike, Walk, Run, or Ride for IBM on Saturday, June 13!

by Kevin Dooley, MD | Jun 10, 2020 | News and Information

JOIN US! On June 13, you can support the cause of inclusion body myositis by biking, walking, running, swimming, or riding in your own town or city. The Million Dollar Bike Ride has become a virtual event this year. Although it is unfortunate that Team Cure IBM cannot...
The Million Dollar Bike Ride Needs YOUR Help!

The Million Dollar Bike Ride Needs YOUR Help!

by Kevin Dooley, MD | Apr 14, 2020 | News and Information

$102,340 Grant Awarded for Inclusion Body Myositis Research

$102,340 Grant Awarded for Inclusion Body Myositis Research

by Kevin Dooley, MD | Feb 5, 2020 | News and Information

Coach Randy Marks Thrives Despite Inclusion Body Myositis

Coach Randy Marks Thrives Despite Inclusion Body Myositis

by Kevin Dooley, MD | Jun 20, 2019 | News and Information

« Older Entries

Recent Posts

  • Abcuro Raises $66 Million for New Phase 3 Ulviprubart Study in IBM
  • Abcuro to Close Long-Term Extension Study of Ulviprubart in Inclusion Body Myositis
  • Ulviprubart in Inclusion Body Myositis—New Results and the Question of Clinically Meaningful Slowing
  • Pioglitazone in Inclusion Body Myositis: An Early but Encouraging Study
  • Ulviprubart in Inclusion Body Myositis—Phase 2/3 Trial Results

Archives

  • August 2026
  • June 2026
  • March 2026
  • February 2026
  • April 2024
  • August 2023
  • September 2022
  • July 2021
  • March 2021
  • August 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • April 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017

Tags

Abcuro actvin a advocacy arimoclomol atrophy biomarker chloroquine clinical trial clinical trial endpoints clinical trials coronavirus COVAD COVID-19 diagnosis Electrical Impedance Myography falls FDA fundraising hand function helpful devices IBMFRS Inclusion Body Myositis Functional Rating Scale inflammation Living with IBM MDBR Million Dollar Bike Ride mitochondria mri muscle biopsies muscle biopsy muscle degeneration muscle strength myositis clinic myostatin patient story personal story Pioglitazone positive attitude rapamycin research specialty care sporadic inclusion body myositis ulviprubart wheelchairs Yale

Support IBM Research

Join Cure IBM in the fight against Inclusion Body Myositis. Your support will help fund research and the development of treatment options for this debilitating disease.

Donate Today

Subscribe to the Cure IBM Newsletter.

Keep in touch and stay informed by subscribing to our quarterly newsletter.

We will be sending you an email soon. Please open the message and follow the instructions to confirm your subscription.

Subscribe

  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2026 Cure IBM | Website design and digital media services by Abaton Consulting

  • Follow
  • Follow